Signals from skin cells control fat cell specialization

July 25, 2019

When cells change to a more specialized type, we call this process cellular differentiation. Scientists have revealed that protein secretions by skin cells known as keratinocytes control the differentiation of subsurface skin fat cells. This discovery could potentially help to treat obesity. Associate Professor Takehiko Ueyama and Professor Naoaki Saito at the Biosignal Research Center of Kobe University led the research team, and the findings were published on July 24 in the online edition of the Journal of Investigative Dermatology.

There are two main types of fat cells: white adipose tissue or "white fat" that stores energy and contributes to obesity, and brown adipose tissue or "brown fat" that consumes energy and helps prevent obesity. White fat can convert to brown fat in the "browning" phenomenon.

Researchers already knew about signaling from subsurface skin fat cells to keratinocytes that promotes cell differentiation. However, there were no clear reports about signaling in the opposite direction (see Figure 1).

In this study, the team found that genetically altered mice with Rac molecules removed from their keratinocytes had extremely thin layers of skin fat (see Figure 2). The team carried out comprehensive genetic analysis of the Rac-deficient mice, comparing them with wild-type mice, and found that the Rac-deficient keratinocytes had notably low levels of six growth factor proteins. When they applied these growth factors to fat precursor cells, they found that simultaneous treatment of factors BMP2 and FGF21 encouraged differentiation into white fat cells, and suppressed differentiation into brown fat cells (see Figure 2). They were able to substitute the effects of BMP2 and FGF21 with a culture medium of human-derived keratinocytes, proving that the growth factor proteins secreted in human keratinocytes contribute to differentiation of fat cells.

We already knew that FGF21 promotes differentiation into brown fat cells, but this study showed that BMP2 inhibits this process. This means that suppressing BMP2 can decrease the number of white fat cells and increase brown fat cells. The team also discovered that simultaneous application of both BMP2 and FGF21 causes fibroblasts - skin pluripotent cells that can produce fat precursor cells - to differentiate into fat cells.

This study proved the existence of differentiation signaling (BMP2 and FGF21 from keratinocytes/skin cells/epidermal cells to fat cells) in the opposite direction to the previous reports (from fat cells to keratinocytes). It shows that paracrine-based differentiation signaling occurs in both directions between cells in the epidermal (surface skin) and intradermal (subsurface skin) layers. This also revealed the potential for transforming the type and composition of subsurface fat cells by controlling the signals from surface skin to subsurface skin and fat layers.

Obesity is a growing problem in modern societies. One way to tackle this disease is influencing the body's metabolism by changing the ratios of white fat cells to brown fat cells. This study revealed that BMP2 and FGF21 secreted from keratinocytes regulate the ratios of skin fat cells. By adjusting levels of BMP2 and FGF21, we could potentially control the ratio of white to brown fat cells. This could include a skin-based anti-obesity treatment - for example, developing a cream to be absorbed through the skin.
-end-


Kobe University

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.